Overweight and obesity represent addressable proximal drivers of chronic disease. 1 The prevalence of overweight and obesity is increasing around the world; by 2050, projections indicate that more than half the adult population worldwide will be living with overweight and obesity, most prominently in China (an estimated 627 million persons). 2 In China, the numbers of persons with overweight and obesity have increased dramatically over the past four decades, contributing to major increases in the risks of noncommunicable diseases — including type 2 diabetes, cardiovascular disease, and cancer — and premature death. 3 Dedicated interventional trials in Chinese populations are part of the . . .
No takes yet. Share an insight, caveat, or question.
Aroda et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: